Van Diest Capital’s Oracle ORCL Stock Holding History

Van Diest Capital’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$426K	Buy	2,893 +1,079	+59%	+$175K	0.33%	78
2025 Q4	$353K	Buy	+1,814	New	+$432K	0.53%	59

Other funds holding ORCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Van Diest Capital's ORCL Position: Q1 2026 in Review

Van Diest Capital increased its Oracle (ORCL) stake by 59% in Q1 2026, buying an estimated $175K and bringing the position to 2,893 shares worth $426K. The position accounts for 0.33% of the portfolio, ranked #78.

Van Diest Capital first reported a position in ORCL in Q4 2025 and has held it in 2 quarters since. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

Van Diest Capital held 2,893 shares of Oracle worth $426K as of Q1 2026.
Van Diest Capital bought 1,079 Oracle shares in Q1 2026, an estimated $175K.
Oracle made up 0.33% of Van Diest Capital's portfolio in Q1 2026, its #78 holding.
Van Diest Capital first reported a position in Oracle in Q4 2025 and has held it in 2 quarters since.
3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Van Diest Capital's 13F filing for Q1 2026, filed 15 May 2026.